Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies

Company About Us Leadership Approach High-Precision Technology Manufacturing Therapies Pipeline Orca-T Orca-Q Scientific Publications Expanded Access Policy Patients & Families Our Purpose Key Terms More Resources Culture & Careers Who We Are Open Positions Newsroom Company About Us Leadership Approach High-Precision Technology Manufacturing Therapies Pipeline Orca-T Orca-Q Scientific Publications Expanded Access Policy Patients & Families […] The post Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematol